The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
Statement from American Society of Clinical Oncology (ASCO) President Michael P. Link, MD, on the Introduction of the Drug Shortage Prevention Act in the U.S. House of Representatives
Cancer patients continue to face shortages of critical therapies for which there are often no acceptable substitutions. Last year, the medical community experienced a record number of shortages and the situation is expected to worsen without action from Congress. The American Society of Clinical Oncology (ASCO) is pleased that U.S. Representatives John Carney [D-DE] and Larry Bucshon [R-IN] have introduced legislation that will begin to address this crisis. By giving the Food and Drug Administration (FDA) greater ability to consider shortage issues in the drug approval and regulatory process, this legislation takes steps in bringing solutions to a dilemma faced by cancer doctors and their patients. ASCO is grateful for the leadership of Reps. Carney and Bucshon and will continue to advocate for legislation that addresses the current drug shortage crisis and will prevent future shortages from occurring.
